Adaptive Biotechnologies ADPT Mrd Business — General And Administrative Expense

Similar metrics at other companies

CAKEAll Other Segments — General And Administrative Expense

$63.93M+6.7%

MBLYAll Other Segments — General And Administrative Expense

$1M0.0%

CIMInvestment Management And Advisory — General and administrative expenses

$10.04M+45.3%

CELHReportable Segment — General and Administrative Expense

$84.05M+113%

IRONSignificant Segment Expense Category — General And Administrative Expense

-$9.03M-31.7%

DJT

DJTSelling General And Administrative Expense

$37.94M+50.7%

Questions, answered.

What is Adaptive Biotechnologies's mrd business — general and administrative expense?

Adaptive Biotechnologies (ADPT) reported mrd business — general and administrative expense of $12.52M in Q1 2026.

How has Adaptive Biotechnologies's mrd business — general and administrative expense changed year-over-year?

Adaptive Biotechnologies's mrd business — general and administrative expense increased by 31.8% year-over-year, from $9.5M to $12.52M.

What is the long-term trend for Adaptive Biotechnologies's mrd business — general and administrative expense?

Over 3 years (2022 to 2025), Adaptive Biotechnologies's mrd business — general and administrative expense has grown at a 9.2% compound annual growth rate (CAGR), from $32.35M to $42.08M.

What does mrd business — general and administrative expense mean?

This includes the overhead costs, such as legal, human resources, and executive management, allocated to the MRD business segment. It reflects the operational efficiency and administrative burden required to support the segment's core business activities.